InsidersTradesSigma
Browse the detailed record of transactions filed by 정진향, Director. Officer active across 2 companies, notably 메디톡스. Cumulatively, 3 disclosures have been logged. The latest transaction was disclosed on 3 March 2026 — Purchase. Regulator: DART (FSS). The full history is accessible without signup.
3 of 3 declarations
Jeong Jin-hyang serves as a Board Member at Medytox, a company specializing in the development of biopharmaceutical products. In this role, he participates in strategic decision-making and oversight of the company's activities. With his experience in corporate governance, Jeong Jin-hyang ensures that the company's practices adhere to the highest standards of transparency and accountability. He is committed to supporting the sustainable growth of the company.